Simon Baron-Cohen


Sir Simon Philip Baron-Cohen is a British clinical psychologist and professor of developmental psychopathology at the University of Cambridge. He is the director of the university's Autism Research Centre and a Fellow of Trinity College.
In 1985, Baron-Cohen formulated the mindblindness theory of autism, the evidence for which he collated and published in 1995. In 1997, he formulated the prenatal sex steroid theory of autism, the key test of which was published in 2015. In 2003, Baron-Cohen formulated the empathising-systemising theory of autism and typical sex differences, the key test of which was published in 2018.
Baron-Cohen has also made major contributions to research on autism prevalence and screening, autism genetics, autism neuroimaging, autism and vulnerability, autism intervention and synaesthesia. He was knighted in the 2021 New Year Honours for services to people with autism. In 2023, Baron-Cohen was awarded the Medical Research Council Millennium Medal.

Early life and education

Baron-Cohen was born into a Jewish family in London, the second son of Judith and Hyman Vivian Baron-Cohen. Baron-Cohen has an elder brother, Dan Baron Cohen, and three younger siblings: brother Ash Baron-Cohen and sisters Suzie and Liz. His cousins include actor and comedian Sacha Baron Cohen and composer Erran Baron Cohen.
His maternal uncle was Canadian racing driver and constructor David Greenblatt. His maternal great-uncle was endocrinologist Robert Benjamin Greenblatt.
Baron-Cohen completed a BA in human sciences at New College, Oxford, and an MPhil in clinical psychology at the Institute of Psychiatry, King's College London. He received a PhD in psychology at University College London; Baron-Cohen's doctoral research was in collaboration with his supervisor, Uta Frith.

Career

Baron-Cohen is professor of developmental psychopathology at the University of Cambridge in the United Kingdom. He is the director of the university's Autism Research Centre and a Fellow of Trinity College.
Baron-Cohen is a Fellow of the British Psychological Society, the British Academy, the Academy of Medical Sciences, the Royal Society of Medicine and the Association for Psychological Science. He is a BPS Chartered Psychologist and a Senior Investigator at the National Institute for Health and Care Research.
Baron-Cohen serves as vice-president of the National Autistic Society, and was the 2012 chair of the National Institute for Health and Care Excellence Guideline Development Group for adults with autism. He has served as vice-president and president of the International Society for Autism Research. Baron-Cohen was the founding co-editor-in-chief of the journal Molecular Autism.
Baron-Cohen was the chair of the Psychology Section of the British Academy. He is also a clinical psychologist who created the first diagnosis clinic in the UK for late autism diagnosis in adults.
Baron-Cohen gave the keynote lecture on the topic of Autism and Human Rights at the United Nations on World Autism Awareness Day in 2017.

Research

The mindblindness theory of autism

Baron-Cohen has worked in autism research for over 40 years, starting in 1982. In 1985, while he was member of the MRC Cognitive Development Unit in London, Baron-Cohen and his colleagues Uta Frith and Alan Leslie formulated the "theory of mind" hypothesis, to explain the social-communication difficulties in autism. ToM is the brain's partially innate mechanism for rapidly making sense of social behavior by effortlessly attributing mental states to others, enabling behavioral prediction and social communication skills. They confirmed this using the false belief test, showing that a typical four-year-old child can infer another person's belief that is different to their own, while autistic children on average are delayed in this ability.
Baron-Cohen's 1995 book, Mindblindness summarized his subsequent experiments in ToM and the disability in ToM in autism. Baron-Cohen went on to show that autistic children are blind to the mentalistic significance of the eyes and show difficulties in advanced ToM, measured by the "reading the mind in the eyes test" that he designed. He conducted the first neuroimaging study of ToM in typical and autistic adults, and studied patients with acquired brain damage, demonstrating lesions in the orbito- and medial-prefrontal cortex and amygdala can impair ToM. Baron-Cohen also reported the first evidence of atypical amygdala function in autism during ToM. In 2017, his team studied 80,000 genotyped individuals who took the eyes test. Baron-Cohen found single nucleotide polymorphisms partly contribute to individual differences on this dimensional trait measure on which autistic people show difficulties. This was the evidence that cognitive empathy/ToM is partly heritable. The National Institutes of Health recommended Baron-Cohen's eyes test as a core measure that should be used as part of the Research Domain Criteria for assessing social cognition.

Empathizing-systemizing (E-S) theory

In 1997, Baron-Cohen developed the empathizing-systemizing theory. Empathizing includes both cognitive empathy and affective empathy. Systemizing is the drive to analyse or construct rule-based systems to understand how things work. A system is defined as anything that follows if-and-then patterns or rules.
The E-S theory argues that typical females on average score higher on empathizing relative to systemizing, and typical males on average score higher on systemizing relative to empathizing. Autistic people are predicted to score as an extreme of the typical male. These predictions were confirmed in a 2018 online study of 600,000 non-autistic people and 36,000 autistic people. This also confirmed that autistic people on average are "hyper-systemizers".
Working with the personal genomics company 23andMe, Baron-Cohen's team studied 56,000 genotyped individuals who had taken the Systemizing Quotient. He and his colleagues found that the common genetic variants associated with systemizing overlapped with the common genetic variants associated with autism. Baron-Cohen concluded that the genetics of autism not only includes genes associated with disability, but also include genes associated with talent in pattern recognition and understanding how things work.

Prenatal neuroendocrinology

Baron-Cohen investigated whether higher levels of prenatal testosterone explain the increased rate of autism among males. In his 2004 book Prenatal Testosterone in Mind, Baron-Cohen put forward the prenatal sex steroid theory of autism. He proposed this theory to understand why autism is more common in males. Using the Cambridge Child Development Project that Baron-Cohen established in 1997, a longitudinal study studying children of 600 women who had undergone amniocentesis in pregnancy, he followed these children postnatally. This study demonstrated, for the first time in humans, how normative variation in amniotic prenatal testosterone levels correlates with individual differences in typical postnatal brain and behavioral development. Baron-Cohen's team discovered that in typical children, amount of eye contact, rate of vocabulary development, quality of social relationships, theory of mind performance, and scores on the empathy quotient are all inversely correlated with prenatal testosterone levels. In contrast, they found that scores on the embedded figures test, on the systemizing quotient, measures of narrow interests, and number of autistic traits are positively correlated with prenatal testosterone levels. Within this study, Baron-Cohen's team conducted the first human neuroimaging studies of brain grey matter regional volumes and brain activity associated with prenatal testosterone. But to really test the theory, Baron-Cohen needed a much larger sample than his Cambridge Child Development Project, autism only occurs in 3% of the population. So, in 2015, he set up a collaboration with the Danish Biobank which has stored over 20 thousand amniotic fluid samples, which Baron-Cohen linked to later diagnosis of autism via the Danish Psychiatric Register. He tested the prenatal androgens and found that children later diagnosed as autistic were exposed to elevated levels of prenatal testosterone, and the Δ4 sex steroid precursors to prenatal testosterone. In 2019, Baron-Cohen tested the same cohort's levels of exposure to prenatal estrogens and again found these were elevated in pregnancies that resulted in autism. Other clues for the theory came from his postnatal hormonal studies which found that autistic adults have elevated circulating androgens in serum and that the autistic brain in women is 'masculinized' in both grey and white matter brain volume. An independent animal model by Xu et al. showed that elevated prenatal testosterone during pregnancy leads to reduced social interest in the offspring. Baron-Cohen's group also studied the rate of autism in offspring of mothers with polycystic ovary syndrome, a medical condition caused by elevated prenatal testosterone. He found that in women with PCOS, the odds of having a child with autism are significantly increased. This has been replicated in three other countries and is in line with the finding that mothers of autistic children themselves have elevated sex steroid hormones. These novel studies provide evidence of the role of prenatal hormones, interacting with genetic predisposition, in the cause of autism.

Other contributions

In 2006, Baron-Cohen proposed the assortative mating theory which states that if individuals with a systemizing or "type S" brain type have a child, the child is more likely to be autistic. One piece of evidence for this theory came from his population study in Eindhoven, where autism rates are twice as high in that city which is an IT hub, compared to other Dutch cities. He also found both mothers and fathers of autistic children score above average on tests of attention to detail, a prerequisite for strong systemizing.
In 2001, Baron-Cohen developed the autism-spectrum quotient, a set of 50 questions that measures how many autistic traits a person has. This was one of the first measures to show that autistic traits run right through the general population and that autistic people on average simply score higher than non-autistic people. The finding that AQ is associated with scientific and mathematical talent has been found in multiple studies, suggesting these may have shared mechanism such as strong systemizing. The AQ has subsequently been used in hundreds of studies including one study of half a million people, showing robust sex differences and higher scores in those who work in STEM. Multiple studies have also shown that both psychological and biological variables correlate with the number of autistic traits a person has.
Baron-Cohen also developed Mindreading, for use in special education. His team also developed The Transporters, an animation series aimed at teaching emotion recognition to younger autistic children, and conducted the first clinical trial of lego therapy in the UK, finding that autistic children improve in social skills following this.
Baron-Cohen has also contributed to applied autism research. He found that autistic people are being failed by the criminal justice system, and have higher rates of suicidality, higher rates of postnatal depression, and higher rates of mental and physical health conditions.